Anti-EFNA5 Antibody Picoband®

EFNA5 antibody

Boster Bio Anti-EFNA5 Antibody Picoband® catalog # A06229-1. Tested in WB, IHC, ELISA applications. This antibody reacts with Human, Mouse, Rat. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.

Product Info Summary

SKU: A06229-1
Size: 100 μg/vial
Reactive Species: Human, Mouse, Rat
Host: Rabbit
Application: ELISA, IHC, WB

Customers Who Bought This Also Bought

Product Name

Anti-EFNA5 Antibody Picoband®

View all EFNA5 Antibodies

SKU/Catalog Number

A06229-1

Size

100 μg/vial

Form

Lyophilized

Description

Boster Bio Anti-EFNA5 Antibody Picoband® catalog # A06229-1. Tested in WB, IHC, ELISA applications. This antibody reacts with Human, Mouse, Rat. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.

Storage & Handling

At -20°C for one year from date of receipt. After reconstitution, at 4°C for one month. It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freezing and thawing.

Cite This Product

Anti-EFNA5 Antibody Picoband® (Boster Biological Technology, Pleasanton CA, USA, Catalog # A06229-1)

Host

Rabbit

Contents

Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.

Clonality

Polyclonal

Immunogen

E.coli-derived human EFNA5 recombinant protein (Position: S39-S199).

Reactive Species

A06229-1 is reactive to EFNA5 in Human, Mouse, Rat

Observed Molecular Weight

26 kDa

Calculated molecular weight

26.3 kDa

Background of EFNA5

Ephrin-A5, a member of the ephrin gene family, prevents axon bundling in cocultures of cortical neurons with astrocytes, a model of late stage nervous system development and differentiation. The EPH and EPH-related receptors comprise the largest subfamily of receptor protein-tyrosine kinases and have been implicated in mediating developmental events, particularly in the nervous system. EPH receptors typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin ligands and receptors have been named by the Eph Nomenclature Committee (1997). Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. The Eph family of receptors are similarly divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands.

Antibody Validation

Boster validates all antibodies on WB, IHC, ICC, Immunofluorescence, and ELISA with known positive control and negative samples to ensure specificity and high affinity, including thorough antibody incubations.

View more details

Applications

A06229-1 is guaranteed for ELISA, IHC, WB Boster Guarantee

Recommend Dilution

ApplicationDilutionSpecies
Western blot0.25-0.5 μg/mlMouse, Rat
Immunohistochemistry(Paraffin-embedded Section)2-5 μg/mlHuman
ELISA0.1-0.5 μg/ml

Tested application

EFNA5 antibody was positively detected by WB in:
rat eye tissue, mouse eye tissue
Suggested blocking solution with 5% non-fat milk or BSA; (*)Recommended protein loading: 20-40 µg per lane
EFNA5 antibody was positively detected by IHC in:
human ovarian cancer tissue, human brain tissue
Use TE buffer pH 9.0 for antigen retrieval; (*) citrate buffer pH 6.0 is an alternative.

Validation Images & Assay Conditions

Loading publications

No publications found

Do you have publications using this product? Share with us and receive a reward. Contact us for more information.

Publications not available. Please try again later.

Product has been cited in publications

No results found matching your query

  • Published: --- Journal: --- Application: --- Impact Factor: --- Species: --- PMID: --- View Article

Have you used Anti-EFNA5 Antibody Picoband®?

Share your experimental results or join a short interview to earn up to $1,000 in product credits or other rewards.

0 Reviews For Anti-EFNA5 Antibody Picoband®

Have a question?

Find answers in Q&As, reviews.

Can't find your answer?

Submit your question

0 Customer Q&As for Anti-EFNA5 Antibody Picoband®

Order DetailsPrice
A06229-1

100μg

$370 $99
A06229-1-Fluoro488

100 μg Fluoro488 conjugated (liquid)

$570
A06229-1-Fluoro550

100 μg Fluoro550 conjugated (liquid)

$570
A06229-1-Fluoro594

100 μg Fluoro594 conjugated (liquid)

$570
A06229-1-Fluoro647

100 μg Fluoro647 conjugated (liquid)

$670
A06229-1-APC

100 μg APC conjugated (liquid)

$820
A06229-1-FITC

100 μg FITC conjugated (liquid)

$570
A06229-1-Cy3

100 μg Cy3 conjugated (liquid)

$570
A06229-1-Biotin

100 μg Biotin conjugated (liquid)

$570
A06229-1-HRP

100 μg HRP conjugated (liquid)

$570
A06229-1-PE

100 μg PE conjugated (liquid)

$820
A06229-1-carrier-free

Carrier Free

$370
Rainbow Button View conjugates

Free Secondary Antibody

FREE  $95.00
FREE  $95.00
$40.00  $80.00
$65.00  $130.00
$67.50  $135.00
$75.00  $150.00
$30.00  $60.00
$75.00  $150.00
$55.00  $110.00
Choose an option to show lead time.
Get A Quote
In stock
Order Product
A06229-1
Buy one primary antibody get one 0.5ml HRP or Biotin secondary antibody for free.
*Sample sizes are prepared on demand and will take extra lead time. (cannot be conjugated)
Special Price $99.00 Regular Price $370.00

Troubleshooting

troubleshooting-box-image

Download troubleshooting handbooks for IHC, Western blot and ELISA for FREE.

Download Free PDFs Now

Boster Guarantee

Guaranteed product quality

Guaranteed product quality

We promise all of our products perform as described in datasheets.

This product is for Research Use Only. Not for use in diagnostic procedures.

Update date: Oct 1, 2026